April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Reactive and infiltrative papillitis in uveitis: response to treatment and use of optic nerve optical coherence tomography for monitoring
Author Affiliations & Notes
  • Lucia Sobrin
    Retina/Uveitis, Harvard Med Mass Eye & Ear Infirmary, Boston, MA
  • Laura Nicholson
    Retina/Uveitis, Harvard Med Mass Eye & Ear Infirmary, Boston, MA
  • Parvathy Pillai
    Retina/Uveitis, Harvard Med Mass Eye & Ear Infirmary, Boston, MA
  • Heeyoon Cho
    Retina/Uveitis, Harvard Med Mass Eye & Ear Infirmary, Boston, MA
    Ophthalmology, Hanyang University College of Medicine, Seoul, Republic of Korea
  • Footnotes
    Commercial Relationships Lucia Sobrin, None; Laura Nicholson, None; Parvathy Pillai, None; Heeyoon Cho, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5809. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lucia Sobrin, Laura Nicholson, Parvathy Pillai, Heeyoon Cho; Reactive and infiltrative papillitis in uveitis: response to treatment and use of optic nerve optical coherence tomography for monitoring. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5809.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To describe the clinical characteristics and response to treatment in patients with reactive or infiltrative papillitis associated with uveitis and to evaluate spectral domain optical coherence tomography (SD-OCT) as a tool for monitoring the response to anti-inflammatory treatment in these patients.

Methods: This IRB-approved, retrospective study included patients with reactive or infiltrative papillitis secondary to uveitis who had optic nerve SD-OCT imaging on the Uveitis Service at the Massachusetts Eye and Ear Infirmary between January 2010 and July 2013. Clinical data, including uveitic inflammatory grade as measured using the Standardization of Uveitis Nomenclature criteria, were obtained from the medical record. Optic nerve imaging was performed with the Heidelberg Spectralis SD-OCT. The imaging protocol included three different measurements: an optic nerve head (ONH) thickness map, a one-point measurement of ONH thickness and a peripapillary retinal nerve fiber layer (RNFL) thickness map. We used a paired t-test to compare mean ONH and peripapillary RNFL thickness measurements at the time of active inflammation with those obtained when uveitis was inactive. For the statistical tests, only one, randomly selected eye of patients who had bilateral disease was analyzed.

Results: Twenty-three eyes of 14 patients were included. Ten patients had reactive papillitis; two were secondary to anterior uveitis and eight were associated with posterior uveitis. The remaining four patients had infiltrative papillitis. Among patients with reactive papillitis, resolution of ONH elevation often lagged behind resolution of uveitis. There was a statistically significant difference in optic nerve thickness by ONH thickness map measurement in active vs. inactive uveitis (569 µm vs. 407 µm, p= .008). Although the one-point ONH and peripapillary RNFL measurements were higher in active uveitis vs. inactive uveitis (625 µm vs. 526 µm and 139 µm vs. 115 µm, respectively), these differences were not statistically significant.

Conclusions: Optic nerve elevation in papillitis secondary to uveitis as quantified by the SD-OCT ONH thickness map correlates with presence vs. resolution of uveitis. Further study is required to determine if the SD-OCT ONH thickness map protocol can be used to non-invasively monitor treatment response in patients with papillitis due to uveitis.

Keywords: 746 uveitis-clinical/animal model • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound) • 557 inflammation  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×